A 29% drop in CLABSI in 23 Hospitals over 2 years Central venous catheters (CVCs) are used for the administration of intravenous fluids, blood products, medications, and parenteral nutrition. They also provide access for hemodialysis and other forms of long-term treatment, such as chemotherapy. Widespread and essential, CVCs are also a frequent cause of healthcare- associated bloodstream infections. It is estimated that 250,000 cases of central line–associated bloodstream infections (CLABSIs) occur in the U.S. every year. According to the CDC, CLABSIs are associated with a mortality rate of 12–25%. Each CLABSI episode costs approximately $22,000, which includes the burdens of additional diagnosis and treatment, and prolonged hospital stays. CLABSI rates can be reduced by ad

Join for free to read